About
SHL Healthcare AB is a global leader in designing, developing, and manufacturing advanced drug delivery systems, particularly autoinjectors and pen injectors. Founded in 1989 by Roger Samuelsson, the company is headquartered in Zug, Switzerland, and operates across Europe, Asia, and the United States, employing around 5,000 people. The company focuses on enabling effective delivery of complex biologics and biosimilar drugs, partnering with pharmaceutical and biotechnology firms. SHL’s products facilitate self-injection treatments for chronic diseases, enhancing patient independence and healthcare outcomes. Their core offerings include autoinjectors for self-administration, pen injectors tailored for various therapeutic needs, and comprehensive end-to-end services that support the entire drug delivery value chain. SHL Healthcare is recognized for its innovation capabilities and strong intellectual property, contributing to its success in a high-growth market.
Technologies
Keywords
Company Information
-
Employees 41
-
Founded 1989
Location
7 Augustendalsvaegen, Stockholms laen, Sweden, 131 52